A-ring bridged steroids as potent inhibitors of aromatase

The design and syntheses of androstenedione derivatives with bridges spanning the 2,19-, 3,19-, 4,19- and 6,19-positions are described. 2,19-Bridged compounds bearing hydroxyl groups on the two-carbon bridge ( 3a and 3b) were designed as stable carbon analogs of potential lactol intermediates in the...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of steroid biochemistry and molecular biology 1993-03, Vol.44 (4), p.409-420
Hauptverfasser: Peet, Norton P., Johnston, J.O'Neal, Burkhart, Joseph P., Wright, C.Lee
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 420
container_issue 4
container_start_page 409
container_title Journal of steroid biochemistry and molecular biology
container_volume 44
creator Peet, Norton P.
Johnston, J.O'Neal
Burkhart, Joseph P.
Wright, C.Lee
description The design and syntheses of androstenedione derivatives with bridges spanning the 2,19-, 3,19-, 4,19- and 6,19-positions are described. 2,19-Bridged compounds bearing hydroxyl groups on the two-carbon bridge ( 3a and 3b) were designed as stable carbon analogs of potential lactol intermediates in the enzymatic conversion of androgens to estrogens. Compounds 3a and 3b are competitive inhibitors of aromatase. Pyran 25 is a potent, time-dependent inhibitor of aromatase with partial NADPH dependence. These data suggest a mechanism of inhibition for 25 which involves both tight-binding competitive and mechanism-based components, with the former predominating. The sulfur, amino, and all carbon analogs of pyran 25 were prepared. Thiopyran 36, piperidine 42 and the all-carbon analog 47 are also time-dependent inhibitors of aromatase. Compound 47 is the most potent inhibitor and its time-dependent inhibition is not NADPH dependent. The kinetics of piperidine 42 suggest uncompetitive inhibition.
doi_str_mv 10.1016/0960-0760(93)90244-Q
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_75682928</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>096007609390244Q</els_id><sourcerecordid>75682928</sourcerecordid><originalsourceid>FETCH-LOGICAL-c386t-2f93803c4ea4f427413ebe56e7f5a226baac2de616d130476bf2fea2e58a81a03</originalsourceid><addsrcrecordid>eNp9kEtLAzEUhYMotVb_gcIsRHQxmtdkJhuhFF9QkIKuw53MTY20k5pMBf-9U1u6dHUX5zuHy0fIOaO3jDJ1R7WiOS0VvdbiRlMuZT47IENWlTpnnNNDMtwjx-QkpU9KqRCsHJBBJUtVFnJI9DiPvp1ndfTNHJssdRiDb1IGKVuFDtsu8-2Hr30XYsqCyyCGJXSQ8JQcOVgkPNvdEXl_fHibPOfT16eXyXiaW1GpLudOi4oKKxGkk7yUTGCNhcLSFcC5qgEsb1Ax1TBB-7dqxx0Cx6KCigEVI3K13V3F8LXG1JmlTxYXC2gxrJMpC1VxzaselFvQxpBSRGdW0S8h_hhGzcaY2egwGx1GC_NnzMz62sVuf10vsdmXdor6_HKXQ7KwcBFa69Mek0oLJniP3W8x7F18e4wmWY-txcZHtJ1pgv__j1_HJIax</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>75682928</pqid></control><display><type>article</type><title>A-ring bridged steroids as potent inhibitors of aromatase</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Peet, Norton P. ; Johnston, J.O'Neal ; Burkhart, Joseph P. ; Wright, C.Lee</creator><creatorcontrib>Peet, Norton P. ; Johnston, J.O'Neal ; Burkhart, Joseph P. ; Wright, C.Lee</creatorcontrib><description>The design and syntheses of androstenedione derivatives with bridges spanning the 2,19-, 3,19-, 4,19- and 6,19-positions are described. 2,19-Bridged compounds bearing hydroxyl groups on the two-carbon bridge ( 3a and 3b) were designed as stable carbon analogs of potential lactol intermediates in the enzymatic conversion of androgens to estrogens. Compounds 3a and 3b are competitive inhibitors of aromatase. Pyran 25 is a potent, time-dependent inhibitor of aromatase with partial NADPH dependence. These data suggest a mechanism of inhibition for 25 which involves both tight-binding competitive and mechanism-based components, with the former predominating. The sulfur, amino, and all carbon analogs of pyran 25 were prepared. Thiopyran 36, piperidine 42 and the all-carbon analog 47 are also time-dependent inhibitors of aromatase. Compound 47 is the most potent inhibitor and its time-dependent inhibition is not NADPH dependent. The kinetics of piperidine 42 suggest uncompetitive inhibition.</description><identifier>ISSN: 0960-0760</identifier><identifier>EISSN: 1879-1220</identifier><identifier>DOI: 10.1016/0960-0760(93)90244-Q</identifier><identifier>PMID: 8476754</identifier><language>eng</language><publisher>Oxford: Elsevier Ltd</publisher><subject>Aromatase Inhibitors ; Biological and medical sciences ; General pharmacology ; Humans ; Kinetics ; Medical sciences ; Molecular Structure ; Pharmaceutical technology. Pharmaceutical industry ; Pharmacology. Drug treatments ; Stereoisomerism ; Steroids - chemical synthesis ; Steroids - chemistry ; Steroids - pharmacology ; Structure-Activity Relationship</subject><ispartof>Journal of steroid biochemistry and molecular biology, 1993-03, Vol.44 (4), p.409-420</ispartof><rights>1993</rights><rights>1993 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c386t-2f93803c4ea4f427413ebe56e7f5a226baac2de616d130476bf2fea2e58a81a03</citedby><cites>FETCH-LOGICAL-c386t-2f93803c4ea4f427413ebe56e7f5a226baac2de616d130476bf2fea2e58a81a03</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/096007609390244Q$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>309,310,314,776,780,785,786,3537,23909,23910,25118,27901,27902,65306</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=4693132$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/8476754$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Peet, Norton P.</creatorcontrib><creatorcontrib>Johnston, J.O'Neal</creatorcontrib><creatorcontrib>Burkhart, Joseph P.</creatorcontrib><creatorcontrib>Wright, C.Lee</creatorcontrib><title>A-ring bridged steroids as potent inhibitors of aromatase</title><title>Journal of steroid biochemistry and molecular biology</title><addtitle>J Steroid Biochem Mol Biol</addtitle><description>The design and syntheses of androstenedione derivatives with bridges spanning the 2,19-, 3,19-, 4,19- and 6,19-positions are described. 2,19-Bridged compounds bearing hydroxyl groups on the two-carbon bridge ( 3a and 3b) were designed as stable carbon analogs of potential lactol intermediates in the enzymatic conversion of androgens to estrogens. Compounds 3a and 3b are competitive inhibitors of aromatase. Pyran 25 is a potent, time-dependent inhibitor of aromatase with partial NADPH dependence. These data suggest a mechanism of inhibition for 25 which involves both tight-binding competitive and mechanism-based components, with the former predominating. The sulfur, amino, and all carbon analogs of pyran 25 were prepared. Thiopyran 36, piperidine 42 and the all-carbon analog 47 are also time-dependent inhibitors of aromatase. Compound 47 is the most potent inhibitor and its time-dependent inhibition is not NADPH dependent. The kinetics of piperidine 42 suggest uncompetitive inhibition.</description><subject>Aromatase Inhibitors</subject><subject>Biological and medical sciences</subject><subject>General pharmacology</subject><subject>Humans</subject><subject>Kinetics</subject><subject>Medical sciences</subject><subject>Molecular Structure</subject><subject>Pharmaceutical technology. Pharmaceutical industry</subject><subject>Pharmacology. Drug treatments</subject><subject>Stereoisomerism</subject><subject>Steroids - chemical synthesis</subject><subject>Steroids - chemistry</subject><subject>Steroids - pharmacology</subject><subject>Structure-Activity Relationship</subject><issn>0960-0760</issn><issn>1879-1220</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1993</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kEtLAzEUhYMotVb_gcIsRHQxmtdkJhuhFF9QkIKuw53MTY20k5pMBf-9U1u6dHUX5zuHy0fIOaO3jDJ1R7WiOS0VvdbiRlMuZT47IENWlTpnnNNDMtwjx-QkpU9KqRCsHJBBJUtVFnJI9DiPvp1ndfTNHJssdRiDb1IGKVuFDtsu8-2Hr30XYsqCyyCGJXSQ8JQcOVgkPNvdEXl_fHibPOfT16eXyXiaW1GpLudOi4oKKxGkk7yUTGCNhcLSFcC5qgEsb1Ax1TBB-7dqxx0Cx6KCigEVI3K13V3F8LXG1JmlTxYXC2gxrJMpC1VxzaselFvQxpBSRGdW0S8h_hhGzcaY2egwGx1GC_NnzMz62sVuf10vsdmXdor6_HKXQ7KwcBFa69Mek0oLJniP3W8x7F18e4wmWY-txcZHtJ1pgv__j1_HJIax</recordid><startdate>19930301</startdate><enddate>19930301</enddate><creator>Peet, Norton P.</creator><creator>Johnston, J.O'Neal</creator><creator>Burkhart, Joseph P.</creator><creator>Wright, C.Lee</creator><general>Elsevier Ltd</general><general>Elsevier Science</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19930301</creationdate><title>A-ring bridged steroids as potent inhibitors of aromatase</title><author>Peet, Norton P. ; Johnston, J.O'Neal ; Burkhart, Joseph P. ; Wright, C.Lee</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c386t-2f93803c4ea4f427413ebe56e7f5a226baac2de616d130476bf2fea2e58a81a03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1993</creationdate><topic>Aromatase Inhibitors</topic><topic>Biological and medical sciences</topic><topic>General pharmacology</topic><topic>Humans</topic><topic>Kinetics</topic><topic>Medical sciences</topic><topic>Molecular Structure</topic><topic>Pharmaceutical technology. Pharmaceutical industry</topic><topic>Pharmacology. Drug treatments</topic><topic>Stereoisomerism</topic><topic>Steroids - chemical synthesis</topic><topic>Steroids - chemistry</topic><topic>Steroids - pharmacology</topic><topic>Structure-Activity Relationship</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Peet, Norton P.</creatorcontrib><creatorcontrib>Johnston, J.O'Neal</creatorcontrib><creatorcontrib>Burkhart, Joseph P.</creatorcontrib><creatorcontrib>Wright, C.Lee</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of steroid biochemistry and molecular biology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Peet, Norton P.</au><au>Johnston, J.O'Neal</au><au>Burkhart, Joseph P.</au><au>Wright, C.Lee</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A-ring bridged steroids as potent inhibitors of aromatase</atitle><jtitle>Journal of steroid biochemistry and molecular biology</jtitle><addtitle>J Steroid Biochem Mol Biol</addtitle><date>1993-03-01</date><risdate>1993</risdate><volume>44</volume><issue>4</issue><spage>409</spage><epage>420</epage><pages>409-420</pages><issn>0960-0760</issn><eissn>1879-1220</eissn><abstract>The design and syntheses of androstenedione derivatives with bridges spanning the 2,19-, 3,19-, 4,19- and 6,19-positions are described. 2,19-Bridged compounds bearing hydroxyl groups on the two-carbon bridge ( 3a and 3b) were designed as stable carbon analogs of potential lactol intermediates in the enzymatic conversion of androgens to estrogens. Compounds 3a and 3b are competitive inhibitors of aromatase. Pyran 25 is a potent, time-dependent inhibitor of aromatase with partial NADPH dependence. These data suggest a mechanism of inhibition for 25 which involves both tight-binding competitive and mechanism-based components, with the former predominating. The sulfur, amino, and all carbon analogs of pyran 25 were prepared. Thiopyran 36, piperidine 42 and the all-carbon analog 47 are also time-dependent inhibitors of aromatase. Compound 47 is the most potent inhibitor and its time-dependent inhibition is not NADPH dependent. The kinetics of piperidine 42 suggest uncompetitive inhibition.</abstract><cop>Oxford</cop><pub>Elsevier Ltd</pub><pmid>8476754</pmid><doi>10.1016/0960-0760(93)90244-Q</doi><tpages>12</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0960-0760
ispartof Journal of steroid biochemistry and molecular biology, 1993-03, Vol.44 (4), p.409-420
issn 0960-0760
1879-1220
language eng
recordid cdi_proquest_miscellaneous_75682928
source MEDLINE; Elsevier ScienceDirect Journals
subjects Aromatase Inhibitors
Biological and medical sciences
General pharmacology
Humans
Kinetics
Medical sciences
Molecular Structure
Pharmaceutical technology. Pharmaceutical industry
Pharmacology. Drug treatments
Stereoisomerism
Steroids - chemical synthesis
Steroids - chemistry
Steroids - pharmacology
Structure-Activity Relationship
title A-ring bridged steroids as potent inhibitors of aromatase
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-06T11%3A53%3A14IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A-ring%20bridged%20steroids%20as%20potent%20inhibitors%20of%20aromatase&rft.jtitle=Journal%20of%20steroid%20biochemistry%20and%20molecular%20biology&rft.au=Peet,%20Norton%20P.&rft.date=1993-03-01&rft.volume=44&rft.issue=4&rft.spage=409&rft.epage=420&rft.pages=409-420&rft.issn=0960-0760&rft.eissn=1879-1220&rft_id=info:doi/10.1016/0960-0760(93)90244-Q&rft_dat=%3Cproquest_cross%3E75682928%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=75682928&rft_id=info:pmid/8476754&rft_els_id=096007609390244Q&rfr_iscdi=true